Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA ’ s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA ’ s new effort for developing and class labeling of vitro companion diagnostics for classes of oncology therapeutic products
Source: Food and Drug Administration - Category: American Health Source Type: news